Page 4 - ஐக்கிய ஆரோக்கியம் குழு இணைக்கப்பட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shares of Navidea Biopharmaceuticals, Inc (NYSE:NAVB) [Trend Analysis] runs in leading trade, it moving down -1.23% to trade at $0.73. The firm has price volatility of 5.45% for a week and 6.27% for a month. Its beta stands at 0.14 times. Cardinal Health Inc. more than doubled its guaranteed cash offer for Lymphoseek rights during this summer’s negotiations with Navidea Biopharmaceuticals Inc., even as the biotech company was fighting for its survival with a creditor in court. Cardinal in June had offered $45 million cash for the North American rights to the radioactive cancer diagnostic aid, with any future payments contingent on drug sales, according to a proxy statement Navidea filed this week seeking shareholder approval of the sale.

United statesUnitedhealth group incorporatedNavidea biopharmaceuticals incCardinal health incNavidea biopharmaceuticalsNorth americanShort ratioஒன்றுபட்டது மாநிலங்களில்ஐக்கிய ஆரோக்கியம் குழு இணைக்கப்பட்டதுகார்டினல் ஆரோக்கியம் இன்க்வடக்கு அமெரிக்கன்குறுகிய ரேஶியோ